The new tool – Metys – is the “first fully integrated, single access, all in one national market measurement solution” available from a contract research organization (CRO), said Barbara Aldieri, senior director, product management at Symphony Health, a PRA Health Sciences wholly-owned subsidiary.
“We are focused on delivering solutions that will move our client’s businesses forward – which means integrating prescriber, patient and payer insights and analytics together in one place. That’s really how impactful, business driving insights are developed,” she told us.
Metys is powered by Symphony’s ‘Integrated Dataverse’ (IDV) and provides customer’s ‘numerous’ benefits, said Aldieri.
“All-in centralized access to prescription, non-retail, integrated sales, source of business and patient national metrics significantly improves clients’ ease and time to insights,” she added.
The tool also provides the diagnosis in prescription transactions and regular updates to support ‘near real-time’ decision making. It also features predefined graphics to visualize performance trends, a report builder, and single-click exports.
PRA Health Sciences acquired Symphony Health for $530m in 2017. The company provides data, analytics, and technology solutions for biopharmaceutical manufacturers, health care providers, and payers.